Kura Oncology, Inc. (KURA)
13.18
+0.12
(+0.92%)
USD |
NASDAQ |
Aug 27, 16:00
13.24
+0.06
(+0.46%)
After-Hours: 20:00
Kura Oncology EPS Diluted (TTM) : -3.362 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.362 |
| March 31, 2026 | -3.348 |
| December 31, 2025 | -3.177 |
| September 30, 2025 | -2.478 |
| June 30, 2025 | -2.258 |
| March 31, 2025 | -2.09 |
| December 31, 2024 | -2.023 |
| September 30, 2024 | -2.356 |
| June 30, 2024 | -2.230 |
| March 31, 2024 | -2.176 |
| December 31, 2023 | -2.084 |
| September 30, 2023 | -2.019 |
| June 30, 2023 | -2.05 |
| March 31, 2023 | -2.039 |
| December 31, 2022 | -2.028 |
| September 30, 2022 | -2.032 |
| June 30, 2022 | -2.004 |
| March 31, 2022 | -1.99 |
| December 31, 2021 | -1.966 |
| September 30, 2021 | -1.920 |
| June 30, 2021 | -1.838 |
| March 31, 2021 | -1.727 |
| December 31, 2020 | -1.686 |
| Date | Value |
|---|---|
| September 30, 2020 | -1.635 |
| June 30, 2020 | -1.576 |
| March 31, 2020 | -1.563 |
| December 31, 2019 | -1.506 |
| September 30, 2019 | -1.534 |
| June 30, 2019 | -1.569 |
| March 31, 2019 | -1.635 |
| December 31, 2018 | -1.729 |
| September 30, 2018 | -1.671 |
| June 30, 2018 | -1.654 |
| March 31, 2018 | -1.604 |
| December 31, 2017 | -1.535 |
| September 30, 2017 | -1.55 |
| June 30, 2017 | -1.54 |
| March 31, 2017 | -1.50 |
| December 31, 2016 | -1.47 |
| September 30, 2016 | -1.51 |
| June 30, 2016 | -1.71 |
| March 31, 2016 | -1.607 |
| December 31, 2015 | -1.454 |
| September 30, 2015 | -1.034 |
| June 30, 2015 | -0.4637 |
| March 31, 2015 | -0.2063 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | -1.176 |
| Fortress Biotech, Inc. | 2.657 |
| Syndax Pharmaceuticals, Inc. | -2.518 |
| Spero Therapeutics, Inc. | 0.1091 |
| Gossamer Bio, Inc. | -0.6959 |